Unravelling benzazepines and aminopyrimidine as multi-target therapeutic repurposing drugs for EGFR V774M mutation in neuroglioma patients.

Jitender SinghKrishan L KhandujaPramod K Avti

Published in: BioImpacts : BI (2023)

Therefore, compounds (ZINC000012503187 and ZINC000068153186) can effectively target both the unaltered/altered EGFRs as multi-target therapeutic repurposing drugs towards neuroglioma.

Keyphrases

end stage renal disease
small cell lung cancer
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
epidermal growth factor receptor
tyrosine kinase
patient reported